[Pharmacological properties and clinical efficacy of Ximency® Combination Tablets]

Nihon Yakurigaku Zasshi. 2017;150(3):153-164. doi: 10.1254/fpj.150.153.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Benzazepines / chemistry
  • Benzazepines / pharmacology*
  • Benzazepines / therapeutic use
  • Carbamates
  • Clinical Trials as Topic
  • Drug Combinations
  • Drug Evaluation, Preclinical
  • Drug Resistance, Viral
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / chemistry
  • Imidazoles / pharmacology*
  • Imidazoles / therapeutic use
  • Indoles / chemistry
  • Indoles / pharmacology*
  • Indoles / therapeutic use
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology*
  • Isoquinolines / therapeutic use
  • Pyrrolidines
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacology*
  • Sulfonamides / therapeutic use
  • Tablets
  • Valine / analogs & derivatives

Substances

  • 8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide
  • Benzazepines
  • Carbamates
  • Drug Combinations
  • Imidazoles
  • Indoles
  • Isoquinolines
  • Pyrrolidines
  • Sulfonamides
  • Tablets
  • Valine
  • daclatasvir
  • asunaprevir